Fig. 1From: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasisPatients with elevated NLR and PLR had worse prognosis. a, b Patients with higher NLR and PLR tended to have worse overall survival (p = 0.008 and p = 0.017). c, d Patients with higher NLR and PLR tended to have worse progression-free survival (p = 0.01 and p = 0.002)Back to article page